
Metpil 12.5mg Tablet XR
Marketer
Alteus Biogenics Pvt Ltd
Salt Composition
Metoprolol Succinate (12.5mg)
Overview Metpil 12.5mg Tablet XR
Cardiopil XR 12.5mg tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain stemming from heart issues), and cardiac arrhythmias (irregular heartbeats). It's also used prophylactically against migraines, recurrent heart attacks, and stroke. Cardiopil XR 12.5mg may be administered independently or in conjunction with other therapies. Dosage and frequency are individualized based on the treated condition and its severity. It can be ingested with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and continuous use might be necessary. Discontinuation can exacerbate underlying conditions; consistent use is vital even with symptom improvement. Common, typically mild and transient, adverse effects include fatigue, cephalalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), vertigo (dizziness), and nausea. Less frequently, dyspnea (shortness of breath) or hypotension (low blood pressure) can occur. Gradual dose escalation minimizes adverse reactions. Report persistent or bothersome side effects to your physician. Prior to initiating treatment, disclose any hepatic (liver) impairment. Cardiopil XR 12.5mg is contraindicated in patients with bradycardia, significant circulatory compromise, severe congestive heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. Always consult your physician to determine suitability and monitor blood pressure regularly to confirm treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.
Uses of Metpil 12.5mg Tablet XR
Managing angina pectoris (chest pain due to heart issues)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (high blood pressure)|Preventing migraine headaches
Major Benefits of Metpil 12.5mg Tablet XR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Metpil 12.5mg Extended-Release Tablets can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats, should be avoided when taking Metpil 12.5mg Extended-Release Tablets.
Common Side effects of Metpil 12.5mg Tablet XR:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metpil 12.5mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metpil 12.5mg Extended-Release tablet whole; do not chew, crush, or divide it. This medication can be taken with or without food, but consistent timing is recommended. For optimal absorption, avoid consuming Metpil 12.5mg Tablet XR with meals high in fat, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats.
How Metpil 12.5mg Tablet XR works:
Extended-release Metpil 12.5mg tablets are a cardioselective beta-adrenergic blocker, reducing heart rate and improving cardiac output.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metpil 12.5mg Tablet XR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metpil 12.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metpil 12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Metpil 12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metpil 12.5mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Metpil 12.5mg extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Metpil 12.5mg tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metpil 12.5mg Tablet XR :
Should you forget a Metpil 12.5mg Tablet XR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metpil 12.5mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |
